Cognitive and graded activity training can alleviate persistent fatigue after stroke: a randomized, controlled trial
Fatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining cognitive therapy (CO) with graded activity training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue-related symptoms....
Uloženo v:
| Vydáno v: | Stroke (1970) Ročník 43; číslo 4; s. 1046 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.04.2012
|
| Témata: | |
| ISSN: | 1524-4628, 1524-4628 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Fatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining cognitive therapy (CO) with graded activity training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue-related symptoms. This study compared the effectiveness of the COGRAT intervention with a CO-only intervention after a 3-month qualification period without intervention.
This randomized, controlled, assessor-blind clinical trial was conducted in 8 rehabilitation centers. Eighty-three stroke patients (>4 months after stroke) were randomly assigned to 12 weeks of CO or COGRAT after qualification. Seventy-three patients completed treatment and 68 were available at follow-up. Primary outcomes (Checklist Individual Strength-subscale Fatigue (CIS-f); self-observation list-fatigue (SOL-f)) and secondary outcomes (Hospital Anxiety and Depression Scale, Stroke-Adapted Sickness Impact Profile, SOL-pain, SOL-sleep-D, 6-minute walk test) were collected at baseline (before and after qualification period) and after treatment (immediate and 6-month follow-up).
The qualification period showed stable outcome measures. Both treatments showed significant beneficial effects on fatigue (CIS-f: η(p)(2)=0.48, P<0.001) and other outcomes (except pain and anxiety) with intention-to-treat analyses. Gains for the COGRAT group exceeded those in the CO group on number of individuals showing clinical improvement on the CIS-f (≥8 points: 58% versus 24%) and on physical endurance (η(p)(2)=0.20, P<0.001).
A 12-week cognitive therapy program can alleviate persistent fatigue after stroke. The best results are obtained when cognitive therapy is augmented with graded activity training. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2704. |
|---|---|
| AbstractList | Fatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining cognitive therapy (CO) with graded activity training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue-related symptoms. This study compared the effectiveness of the COGRAT intervention with a CO-only intervention after a 3-month qualification period without intervention.BACKGROUND AND PURPOSEFatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining cognitive therapy (CO) with graded activity training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue-related symptoms. This study compared the effectiveness of the COGRAT intervention with a CO-only intervention after a 3-month qualification period without intervention.This randomized, controlled, assessor-blind clinical trial was conducted in 8 rehabilitation centers. Eighty-three stroke patients (>4 months after stroke) were randomly assigned to 12 weeks of CO or COGRAT after qualification. Seventy-three patients completed treatment and 68 were available at follow-up. Primary outcomes (Checklist Individual Strength-subscale Fatigue (CIS-f); self-observation list-fatigue (SOL-f)) and secondary outcomes (Hospital Anxiety and Depression Scale, Stroke-Adapted Sickness Impact Profile, SOL-pain, SOL-sleep-D, 6-minute walk test) were collected at baseline (before and after qualification period) and after treatment (immediate and 6-month follow-up).METHODSThis randomized, controlled, assessor-blind clinical trial was conducted in 8 rehabilitation centers. Eighty-three stroke patients (>4 months after stroke) were randomly assigned to 12 weeks of CO or COGRAT after qualification. Seventy-three patients completed treatment and 68 were available at follow-up. Primary outcomes (Checklist Individual Strength-subscale Fatigue (CIS-f); self-observation list-fatigue (SOL-f)) and secondary outcomes (Hospital Anxiety and Depression Scale, Stroke-Adapted Sickness Impact Profile, SOL-pain, SOL-sleep-D, 6-minute walk test) were collected at baseline (before and after qualification period) and after treatment (immediate and 6-month follow-up).The qualification period showed stable outcome measures. Both treatments showed significant beneficial effects on fatigue (CIS-f: η(p)(2)=0.48, P<0.001) and other outcomes (except pain and anxiety) with intention-to-treat analyses. Gains for the COGRAT group exceeded those in the CO group on number of individuals showing clinical improvement on the CIS-f (≥8 points: 58% versus 24%) and on physical endurance (η(p)(2)=0.20, P<0.001).RESULTSThe qualification period showed stable outcome measures. Both treatments showed significant beneficial effects on fatigue (CIS-f: η(p)(2)=0.48, P<0.001) and other outcomes (except pain and anxiety) with intention-to-treat analyses. Gains for the COGRAT group exceeded those in the CO group on number of individuals showing clinical improvement on the CIS-f (≥8 points: 58% versus 24%) and on physical endurance (η(p)(2)=0.20, P<0.001).A 12-week cognitive therapy program can alleviate persistent fatigue after stroke. The best results are obtained when cognitive therapy is augmented with graded activity training. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2704.CONCLUSIONSA 12-week cognitive therapy program can alleviate persistent fatigue after stroke. The best results are obtained when cognitive therapy is augmented with graded activity training. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2704. Fatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining cognitive therapy (CO) with graded activity training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue-related symptoms. This study compared the effectiveness of the COGRAT intervention with a CO-only intervention after a 3-month qualification period without intervention. This randomized, controlled, assessor-blind clinical trial was conducted in 8 rehabilitation centers. Eighty-three stroke patients (>4 months after stroke) were randomly assigned to 12 weeks of CO or COGRAT after qualification. Seventy-three patients completed treatment and 68 were available at follow-up. Primary outcomes (Checklist Individual Strength-subscale Fatigue (CIS-f); self-observation list-fatigue (SOL-f)) and secondary outcomes (Hospital Anxiety and Depression Scale, Stroke-Adapted Sickness Impact Profile, SOL-pain, SOL-sleep-D, 6-minute walk test) were collected at baseline (before and after qualification period) and after treatment (immediate and 6-month follow-up). The qualification period showed stable outcome measures. Both treatments showed significant beneficial effects on fatigue (CIS-f: η(p)(2)=0.48, P<0.001) and other outcomes (except pain and anxiety) with intention-to-treat analyses. Gains for the COGRAT group exceeded those in the CO group on number of individuals showing clinical improvement on the CIS-f (≥8 points: 58% versus 24%) and on physical endurance (η(p)(2)=0.20, P<0.001). A 12-week cognitive therapy program can alleviate persistent fatigue after stroke. The best results are obtained when cognitive therapy is augmented with graded activity training. Clinical Trial Registration- URL: http://www.trialregister.nl. Unique identifier: NTR2704. |
| Author | Geurts, Alexander C Fasotti, Luciano Rietveld, Toni C M Zedlitz, Aglaia M E E |
| Author_xml | – sequence: 1 givenname: Aglaia M E E surname: Zedlitz fullname: Zedlitz, Aglaia M E E email: a.zedlitz@donders.ru.nl organization: Donders Centre for Cognition, Radboud University Nijmegen, Spinozabuilding, Mont 3, B02.09, PO Box 9104, Nijmegen, The Netherlands, 6500. a.zedlitz@donders.ru.nl – sequence: 2 givenname: Toni C M surname: Rietveld fullname: Rietveld, Toni C M – sequence: 3 givenname: Alexander C surname: Geurts fullname: Geurts, Alexander C – sequence: 4 givenname: Luciano surname: Fasotti fullname: Fasotti, Luciano |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22308241$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkFtLAzEQhYNUbL38A5G8-WJrLrvZrG-lqBWFgtbnMsnOlug2W5NU0F9vwAo-zczhnA_OHJOB7z0Scs7ZhHPFr1-Wz4vH2-l8mk8-UVJwXh2QES9FMS6U0IN_-5Acx_jGGBNSl0dkKIRkWhR8RNKsX3uX3CdS8A1dB2iwoWCz4tIXTQGcd35NLXgKXYefDhLSLYboYkKfaAvJrXc53SYMNKbQv-MNBRoyrt-4b2yuqO191nO6yUAH3Sk5bKGLeLafJ-T17nY5m4-fFvcPs-nT2Eqp0tgaDgKVbZS2miuQFWOGcQEt01qXpRCGV63JnQCNapRVFRSqtoWRpja6Eifk8pe7Df3HDmNabVy02HXgsd_FVV3WXDIm6-y82Dt3ZoPNahvcBsLX6u9R4gc-C2-M |
| CitedBy_id | crossref_primary_10_1097_RNJ_0000000000000304 crossref_primary_10_1177_17474930231189135 crossref_primary_10_1186_s12883_017_0979_y crossref_primary_10_1136_jnnp_2017_316007 crossref_primary_10_1016_j_scispo_2015_04_003 crossref_primary_10_1080_09602011_2015_1078820 crossref_primary_10_1186_s40814_023_01300_7 crossref_primary_10_3390_jcm9030621 crossref_primary_10_1097_PHM_0000000000000976 crossref_primary_10_1111_ijs_12428 crossref_primary_10_1177_17474930231152132 crossref_primary_10_1038_s41598_018_26279_7 crossref_primary_10_1016_j_jocn_2025_111418 crossref_primary_10_1080_02699052_2024_2311346 crossref_primary_10_1016_j_jpsychores_2022_111039 crossref_primary_10_1097_NPT_0000000000000290 crossref_primary_10_1016_j_apmr_2018_12_017 crossref_primary_10_1007_s00406_013_0448_6 crossref_primary_10_3109_09638288_2016_1161833 crossref_primary_10_3389_fneur_2025_1564347 crossref_primary_10_1177_0308022618800184 crossref_primary_10_1177_0269215514559987 crossref_primary_10_3390_ph18020261 crossref_primary_10_1007_s00134_021_06368_4 crossref_primary_10_1038_s41393_025_01067_z crossref_primary_10_1007_s00296_023_05520_1 crossref_primary_10_1080_10749357_2024_2304966 crossref_primary_10_1177_0308022620963741 crossref_primary_10_3389_fresc_2022_811465 crossref_primary_10_1177_0269215516687101 crossref_primary_10_2147_JMDH_S465902 crossref_primary_10_1016_j_apmr_2017_02_031 crossref_primary_10_1080_09602011_2017_1326945 crossref_primary_10_1080_09638288_2016_1213897 crossref_primary_10_1016_j_jstrokecerebrovasdis_2025_108297 crossref_primary_10_1007_s13311_016_0451_5 crossref_primary_10_1016_j_apmr_2024_06_023 crossref_primary_10_1161_STROKEAHA_123_046064 crossref_primary_10_1016_j_amepre_2022_01_026 crossref_primary_10_1016_S1474_4422_14_70016_X crossref_primary_10_1007_s00415_024_12327_y crossref_primary_10_1017_BrImp_2022_12 crossref_primary_10_1016_j_jpsychores_2025_112084 crossref_primary_10_1007_s11060_017_2454_4 crossref_primary_10_1371_journal_pone_0324591 crossref_primary_10_1016_j_mehy_2015_10_001 crossref_primary_10_1080_10749357_2024_2408997 crossref_primary_10_1177_17423953211039783 crossref_primary_10_1186_s12984_023_01241_5 crossref_primary_10_1007_s11065_023_09624_0 crossref_primary_10_1186_s12883_015_0438_6 crossref_primary_10_1177_0269215515626232 crossref_primary_10_3389_fneur_2021_663830 crossref_primary_10_1371_journal_pone_0183286 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105628 crossref_primary_10_1016_j_gerinurse_2025_01_029 crossref_primary_10_3389_fphys_2025_1492221 crossref_primary_10_1097_PHM_0000000000001063 crossref_primary_10_3389_fneur_2020_00337 crossref_primary_10_1371_journal_pone_0255538 crossref_primary_10_3109_21679169_2013_792868 crossref_primary_10_5402_2012_629589 crossref_primary_10_1097_WCO_0000000000000260 crossref_primary_10_1016_S1474_4422_18_30233_3 crossref_primary_10_1089_neu_2016_4885 crossref_primary_10_1177_0269215514523631 crossref_primary_10_1186_1471_2377_14_20 crossref_primary_10_53044_jinr_2024_0029 crossref_primary_10_1038_nrneurol_2017_117 crossref_primary_10_1080_09638288_2024_2438253 crossref_primary_10_1097_HTR_0000000000000931 crossref_primary_10_23736_S0022_4707_17_07749_0 crossref_primary_10_1111_ane_13665 crossref_primary_10_1161_STROKEAHA_114_006647 crossref_primary_10_3390_bs10070116 crossref_primary_10_1016_j_brat_2017_11_004 crossref_primary_10_1007_s10049_021_00892_y crossref_primary_10_1136_svn_2018_000155 crossref_primary_10_1080_09638288_2024_2382908 crossref_primary_10_1179_1074935714Z_0000000015 crossref_primary_10_1016_j_resplu_2023_100546 crossref_primary_10_1177_15459683231209170 crossref_primary_10_1016_j_apmr_2017_03_004 crossref_primary_10_1016_j_pmr_2023_06_028 crossref_primary_10_1080_09602011_2015_1127820 crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_07_008 crossref_primary_10_1136_jnnp_2014_308784 crossref_primary_10_1177_17474930221138701 crossref_primary_10_1161_JAHA_121_022588 crossref_primary_10_1212_WNL_0b013e3182a9f59b crossref_primary_10_1080_09602011_2017_1344132 crossref_primary_10_1177_1747493019847334 crossref_primary_10_1177_15394492221087968 crossref_primary_10_1080_09638288_2025_2491123 crossref_primary_10_1055_a_1526_7474 crossref_primary_10_1080_09602011_2019_1589530 crossref_primary_10_1016_j_resuscitation_2021_02_012 crossref_primary_10_1080_09602011_2024_2383337 crossref_primary_10_1017_BrImp_2016_4 crossref_primary_10_1007_s10865_016_9749_3 crossref_primary_10_1111_ene_16570 crossref_primary_10_1017_S0317167100015353 crossref_primary_10_1161_STROKEAHA_115_009534 crossref_primary_10_1007_s40520_022_02179_9 crossref_primary_10_1080_01616412_2025_2551868 crossref_primary_10_1177_02692155251371608 crossref_primary_10_2147_JMDH_S434312 crossref_primary_10_1016_j_apmr_2025_02_001 crossref_primary_10_1177_17474930211006295 crossref_primary_10_1161_STR_0000000000000098 crossref_primary_10_1016_j_msard_2023_104529 crossref_primary_10_1161_STROKEAHA_120_032979 crossref_primary_10_1186_s12912_014_0052_8 crossref_primary_10_3390_medicina59122146 crossref_primary_10_3389_fneur_2023_1298915 crossref_primary_10_1007_s11940_025_00826_w crossref_primary_10_5014_ajot_2015_016170 crossref_primary_10_1016_j_pneurobio_2012_07_004 crossref_primary_10_1212_WNL_0b013e31826d604e crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_09_015 crossref_primary_10_3390_neurolint13010008 crossref_primary_10_1016_j_ergon_2023_103506 crossref_primary_10_4103_ijprm_ijprm_5_18 crossref_primary_10_1080_09593985_2016_1204402 crossref_primary_10_1161_STROKEAHA_119_023552 crossref_primary_10_1177_15459683231219266 crossref_primary_10_1080_17518423_2022_2052374 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1161/STROKEAHA.111.632117 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1524-4628 |
| ExternalDocumentID | 22308241 |
| Genre | Multicenter Study Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ ABASU ABBUW ABDIG ABJNI ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACIJW ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CGR CS3 CUY CVF DIK DIWNM DU5 DUNZO E.X E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A NPM N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YCJ YFH YHZ YQJ YYP ZB8 ZGI ZZMQN 7X8 AAFWJ ABPXF ADGHP ADKSD |
| ID | FETCH-LOGICAL-c336t-cb1a2e6cd68c816a3700b012af08885522b17fb238aeb6d6c67a469c4b3b9b872 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 153 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000302124200026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1524-4628 |
| IngestDate | Thu Oct 02 07:13:53 EDT 2025 Thu Apr 03 07:01:02 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c336t-cb1a2e6cd68c816a3700b012af08885522b17fb238aeb6d6c67a469c4b3b9b872 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| PMID | 22308241 |
| PQID | 959130039 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_959130039 pubmed_primary_22308241 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-04-01 |
| PublicationDateYYYYMMDD | 2012-04-01 |
| PublicationDate_xml | – month: 04 year: 2012 text: 2012-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Stroke (1970) |
| PublicationTitleAlternate | Stroke |
| PublicationYear | 2012 |
| References | 22308245 - Stroke. 2012 Apr;43(4):933-4 |
| References_xml | – reference: 22308245 - Stroke. 2012 Apr;43(4):933-4 |
| SSID | ssj0002385 |
| Score | 2.4533987 |
| Snippet | Fatigue is a common, persistent consequence of stroke, and no evidence-based treatments are currently available to alleviate fatigue. A new treatment combining... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1046 |
| SubjectTerms | Adolescent Adult Aged Cognitive Therapy - methods Female Follow-Up Studies Humans Male Mental Fatigue - etiology Mental Fatigue - therapy Middle Aged Stroke - complications Stroke Rehabilitation Time Factors |
| Title | Cognitive and graded activity training can alleviate persistent fatigue after stroke: a randomized, controlled trial |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22308241 https://www.proquest.com/docview/959130039 |
| Volume | 43 |
| WOSCitedRecordID | wos000302124200026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELXYhLiwL2WTDxwJTeLEjrmgqqJCQhTEIvVWjZcgBCSlSXvg6xknKZwQBy65OYpmJjPPsz1CTngoA2CI3GwcSi_SCfcgYsLzITGBG0cAiCqyCdHvJ4OBvGt6c4qmrXLmEytHbXLtcuRtGUtXeWHyYvThOdIoV1xtGDTmySJDJOM6usTgZ1k4RqO4WpcaRp4bwWwm5xDjtB8e72-vLztXHecyzjjDa5D4HWNWsaa39s-vXCerDcikndoqNsiczTbJ8k1TRt8iZXfWNEQhM_R5DMYa6kYcHJMEndFGUBQ7dVwrU9SfpSOXWkOjyEqaoj6fJ3jaMYzTohznr_acAsXAZ_L3l09rTmnTBP-Gb66oQbbJU-_ysXvlNfQLnmaMl55WAYSWa8MTnQQcmPBd1jSEFD1TEiNwU4FIFUoZrOKGay4AL9s6UkxJlYhwhyxkeWb3CJWJRqPgEnwfIhNESsgglakPWohYWWgROhPnEM3b1Swgs_mkGH4LtEV2a5UMR_UajiECG8QvUbD_9-EDsoJAJ6w7bg7JYoq_tj0iS3pavhTj48ps8Nm_u_kCX4zNUQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cognitive+and+graded+activity+training+can+alleviate+persistent+fatigue+after+stroke%3A+a+randomized%2C+controlled+trial&rft.jtitle=Stroke+%281970%29&rft.au=Zedlitz%2C+Aglaia+M+E+E&rft.au=Rietveld%2C+Toni+C+M&rft.au=Geurts%2C+Alexander+C&rft.au=Fasotti%2C+Luciano&rft.date=2012-04-01&rft.eissn=1524-4628&rft.volume=43&rft.issue=4&rft.spage=1046&rft_id=info:doi/10.1161%2FSTROKEAHA.111.632117&rft_id=info%3Apmid%2F22308241&rft_id=info%3Apmid%2F22308241&rft.externalDocID=22308241 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4628&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4628&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4628&client=summon |